Literature DB >> 21902185

Human butyrylcholinesterase-cocaine binding pathway and free energy profiles by molecular dynamics and potential of mean force simulations.

Xiaoqin Huang1, Fang Zheng, Chang-Guo Zhan.   

Abstract

In the present study, we have performed combined molecular dynamics and potential of mean force (PMF) simulations to determine the enzyme-substrate (ES) binding pathway and the corresponding free energy profiles for wild-type butyrylcholinesterase (BChE) binding with (-)/(+)-cocaine and for the A328W/Y332G mutant binding with (-)-cocaine. According to the PMF simulations, for each ES binding system, the substrate first binds with the enzyme at a peripheral anionic site around the entrance of the active-site gorge to form the first ES complex (ES1-like) during the binding process. Further evolution from the ES1-like complex to the nonprereactive ES complex is nearly barrierless, with a free energy barrier lower than 1.0 kcal/mol. So, the nonprereactive ES binding process should be very fast. The rate-determining step of the entire ES binding process is the subsequent evolution from the nonprereactive ES complex to the prereactive ES complex. Further accounting for the entire ES binding process, the PMF-based simulations qualitatively reproduced the relative order of the experimentally derived binding free energies (ΔG(bind)), although the simulations systematically overestimated the magnitude of the binding affinity and systematically underestimated the differences between the ΔG(bind) values. The obtained structural and energetic insights into the entire ES binding process provide a valuable base for future rational design of high-activity mutants of BChE as candidates for an enzyme therapy for cocaine overdose and abuse.
© 2011 American Chemical Society

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21902185      PMCID: PMC3179575          DOI: 10.1021/jp2047807

Source DB:  PubMed          Journal:  J Phys Chem B        ISSN: 1520-5207            Impact factor:   2.991


  27 in total

1.  Computational design of a human butyrylcholinesterase mutant for accelerating cocaine hydrolysis based on the transition-state simulation.

Authors:  Daquan Gao; Hoon Cho; Wenchao Yang; Yongmei Pan; Guangfu Yang; Hsin-Hsiung Tai; Chang-Guo Zhan
Journal:  Angew Chem Int Ed Engl       Date:  2006-01-16       Impact factor: 15.336

2.  Role of aspartate 70 and tryptophan 82 in binding of succinyldithiocholine to human butyrylcholinesterase.

Authors:  P Masson; P Legrand; C F Bartels; M T Froment; L M Schopfer; O Lockridge
Journal:  Biochemistry       Date:  1997-02-25       Impact factor: 3.162

3.  Peripheral cocaine-blocking agents: new medications for cocaine dependence. An introduction to immunological and enzymatic approaches to treating cocaine dependence reported by Fox, Gorelick and Cohen in the immediately succeeding articles (see pages 153-174).

Authors:  S Sparenborg; F Vocci; S Zukin
Journal:  Drug Alcohol Depend       Date:  1997-12-15       Impact factor: 4.492

Review 4.  Structure and functions of acetylcholinesterase and butyrylcholinesterase.

Authors:  J Massoulié; J Sussman; S Bon; I Silman
Journal:  Prog Brain Res       Date:  1993       Impact factor: 2.453

5.  Modeling evolution of hydrogen bonding and stabilization of transition states in the process of cocaine hydrolysis catalyzed by human butyrylcholinesterase.

Authors:  Daquan Gao; Chang-Guo Zhan
Journal:  Proteins       Date:  2006-01-01

6.  Activities of the enantiomers of cocaine and some related compounds as substrates and inhibitors of plasma butyrylcholinesterase.

Authors:  S J Gatley
Journal:  Biochem Pharmacol       Date:  1991-04-15       Impact factor: 5.858

Review 7.  Enhancing cocaine metabolism with butyrylcholinesterase as a treatment strategy.

Authors:  D A Gorelick
Journal:  Drug Alcohol Depend       Date:  1997-12-15       Impact factor: 4.492

8.  Catalytic mechanism and energy barriers for butyrylcholinesterase-catalyzed hydrolysis of cocaine.

Authors:  Chang-Guo Zhan; Daquan Gao
Journal:  Biophys J       Date:  2005-12       Impact factor: 4.033

9.  Fundamental reaction mechanism for cocaine hydrolysis in human butyrylcholinesterase.

Authors:  Chang-Guo Zhan; Fang Zheng; Donald W Landry
Journal:  J Am Chem Soc       Date:  2003-03-05       Impact factor: 15.419

10.  Free-energy perturbation simulation on transition states and redesign of butyrylcholinesterase.

Authors:  Wenchao Yang; Yongmei Pan; Fang Zheng; Hoon Cho; Hsin-Hsiung Tai; Chang-Guo Zhan
Journal:  Biophys J       Date:  2009-03-04       Impact factor: 4.033

View more
  6 in total

1.  Free energy profiles of cocaine esterase-cocaine binding process by molecular dynamics and potential of mean force simulations.

Authors:  Yuxin Zhang; Xiaoqin Huang; Keli Han; Fang Zheng; Chang-Guo Zhan
Journal:  Chem Biol Interact       Date:  2016-05-06       Impact factor: 5.192

2.  Ensemble Molecular Dynamics of a Protein-Ligand Complex: Residual Inhibitor Entropy Enhances Drug Potency in Butyrylcholinesterase.

Authors:  Eric J Sorin; Walter Alvarado; Samantha Cao; Amethyst Radcliffe; Phuc La; Yi An
Journal:  Bioenergetics       Date:  2017-01-08

3.  Binding structures and energies of the human neonatal Fc receptor with human Fc and its mutants by molecular modeling and dynamics simulations.

Authors:  Xiaoqin Huang; Fang Zheng; Chang-Guo Zhan
Journal:  Mol Biosyst       Date:  2013-09-20

4.  Reaction Pathway and Free Energy Profile for Cocaine Hydrolase-Catalyzed Hydrolysis of (-)-Cocaine.

Authors:  Junjun Liu; Chang-Guo Zhan
Journal:  J Chem Theory Comput       Date:  2012-03-06       Impact factor: 6.006

Review 5.  A Comprehensive Review of Cholinesterase Modeling and Simulation.

Authors:  Danna De Boer; Nguyet Nguyen; Jia Mao; Jessica Moore; Eric J Sorin
Journal:  Biomolecules       Date:  2021-04-15

6.  Computational and experimental insights into the mechanism of substrate recognition and feedback inhibition of protoporphyrinogen oxidase.

Authors:  Ge-Fei Hao; Ying Tan; Sheng-Gang Yang; Zhi-Fang Wang; Chang-Guo Zhan; Zhen Xi; Guang-Fu Yang
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.